Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome

Fig. 1

Oxygenation and IL-6 serum concentrations after FX06 treatment. a The difference in oxygenation compared to baseline (before FX06 treatment). paO2, partial pressure arterial oxygen; FiO2, fraction of inspired oxygen. b The course of interleukin 6 during the treatment with FX06. Data are presented as mean ± standard deviation

Back to article page

Critical Care

ISSN: 1364-8535